Agilent Technologies (A) cash flow statement

Life Sciences Tools & Services · NYSE · Health Care

$172.22 -0.40% Close Nov 17, 2026 Live

TrendArc score 65 of 100 · Health 7.9 · Momentum 7.9 · Moat 6.6 · scored Nov 17, 2026 · How the score works

Free cash flow, fiscal year to October 31, 2025

$1.2 billion

down 16.1% from the year before

Agilent Technologies generated $1.2 billion of free cash flow in the fiscal year to October 2025: $1.6 billion of cash from operations less $407 million of capital spending. That was 16.6% of revenue, against 21.1% the year before. Over the last four quarters, to July 31, 2026, it was $1.3 billion.

What stands out

  • Over the five fiscal years to October 2025 it paid $5.1 billion in dividends and net share repurchases, 80% of its free cash flow over the same years.
  • Cash dividends paid rose in each of the last five fiscal years, from $222 million to $282 million in total.

Each sentence is written by a fixed rule from the figures on this page.

Free cash flow and net income, the last 10 fiscal years

$500M$1.00B$1.50B2016201720182019202020212022202320242025$654MFree cash flow $1.15BNet income $1.30B$500M$1.00B$1.50B20172019202120232025Free cash flow $1.15BNet income $1.30B

Fiscal years, each labelled by the calendar year it ended in. Every figure is in the statement below.

Where the cash wentFiscal year to October 31, 2025

  1. Cash from operations 1.56
  2. Capital spending -0.41
  3. Free cash flow 1.15
  4. Investments bought and sold, net 0.01
  5. Net share repurchases -0.35
  6. Dividends -0.28
  7. Debt and other -0.07
  8. Net change in cash 0.46

In billions of US dollars. Outflows are grey, not red: a buyback is not a loss. "Debt and other" closes the gap to the reported change in cash. Buying marketable securities moves cash into short-term investments; the balance sheet shows both.

Cash flow statement, the last 10 fiscal years

In billions of US dollars. Each column is a fiscal year, named by the month it ended; the first column adds up the last four quarters. Cash paid out is a negative number.
Fiscal year toLast 4 quarters
to Jul 2026
Oct 2025Oct 2024Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016
Operating activities
Net income1.301.291.241.251.210.721.070.320.680.46
Depreciation and amortisation0.290.260.270.320.320.310.240.210.210.25
Stock-based pay0.130.130.130.110.130.110.080.070.070.060.06
Working capital and other items-0.160.080.15-0.38-0.16-0.19-0.360.49-0.070.03
Cash from operations1.611.561.751.771.311.490.921.021.090.890.79
Investing activities
Capital spending-0.34-0.41-0.38-0.30-0.29-0.19-0.12-0.15-0.18-0.18-0.14
Businesses bought and sold, net0.00-0.860.00-0.05-0.550.00-1.41-0.52-0.13-0.26
Investments bought and sold, net0.01-0.02-0.010.01-0.01-0.03-0.03-0.010.000.16
Cash from investing-0.39-1.26-0.31-0.34-0.75-0.15-1.59-0.70-0.30-0.24
Financing activities
Debt issued or repaid, net-0.040.63-0.040.030.35-0.050.60-0.210.110.26
Shares issued less bought back-0.30-0.35-1.07-0.51-1.08-0.73-0.41-0.67-0.37-0.13-0.37
Dividends paid-0.29-0.28-0.27-0.27-0.25-0.24-0.22-0.21-0.19-0.17-0.15
Other financing-0.04-0.03-0.12-0.07-0.08-0.04-0.02-0.03-0.01-0.01
Cash from financing-0.71-0.75-0.93-1.37-0.70-0.72-0.30-0.80-0.20-0.27
Exchange rate effect0.010.000.01-0.040.000.000.00-0.020.010.00
Net change in cash0.46-0.260.54-0.430.040.06-0.87-0.430.390.29
Free cash flow
Free cash flow1.271.151.371.471.021.300.800.870.910.710.65
Free cash flow margin17.2%16.6%21.1%21.6%14.9%20.5%15.0%16.8%18.5%15.9%15.6%
Free cash flow per share$4.04$4.72$4.98$3.40$4.23$2.57$2.72$2.80$2.19$1.99

Shares issued less bought back is the cash from shares sold less the cash paid for shares bought back (negative when more was bought back), and includes tax withheld when employees' shares vest. Working capital and other items is cash from operations less net income, depreciation and amortisation, and stock-based pay (calculated by TrendArc). Company filings as standardised by Tiingo; calculations by TrendArc. Rebuilt nightly.

Agilent Technologies against its peers

CompanyFiscal year toFree cash flowFree cash flow margin
Bio-TechneTECH Jun 2026$263M21.7%
IlluminaILMN Dec 2025$931M21.4%
Mettler ToledoMTD Dec 2025$849M21.1%
WatersWAT Dec 2025$543M17.1%
Agilent TechnologiesA Oct 2025$1.15B16.6%
IQVIAIQV Dec 2025$2.13B13.0%
Charles River LaboratoriesCRL Dec 2025$518M12.9%
Peer median19.1%

Each company's newest fiscal year; some end in other months. The peers are the stock card's peer group.

Next

Follow Agilent Technologies with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes Agilent Technologies from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.